#Trumps cult animosity shows up trial

The recount is unlikely to satisfy the president, who declared on Twitter on Saturday, “ The hand recount taking place in Georgia is a waste of time. The state government of Georgia, including Secretary of State, is scheduled to certify their election results Friday. Coastal Chatham County had counted all but a few absentee ballots, all but one precinct of Election Day ballots, and had started counting early voting ballots by early Sunday.” Counties will announce their results when all recounting is finished. Gwinnett County expected to cross the finish line Monday.

In the state of Georgia, the hand recount began Friday and is continuing, although some counties have completed their recount: “Fulton, Georgia’s most populous county, finished recounting votes shortly before 4 p.m. Meanwhile, in the States and in the Courtrooms. We must work together to get through the next three months.” Former FDA commissioner Scott Gottlieb summarizes it well: “ The acute phase of the U.S. We’re almost out of this ordeal, my friends. While nothing is guaranteed, the success of two vaccines suggests that other vaccines might work as well - or that, at minimum, one approach of neutralizing the virus is likely to illuminate other potential paths. Back in October, J&J paused testing, and “ after a thorough evaluation of a serious medical event experienced by one study participant, no clear cause has been identified.” The AstraZeneca and Oxford vaccine testing also paused earlier this fall, but resumed after a few days. Johnson & Johnson’s vaccine is still in late-stage testing, but should have results by the end of the year. population to immunize about 20 million individuals in the month of December, and another 25-30 million per month on an ongoing basis from there on,” he said. Moncef Slaoui, scientific head of Operation Warp Speed, said that Americans could be getting vaccinated as soon as next month: “ We plan to have enough vaccine doses available for use in the U.S. (Or at least started by the end of the year both vaccines require two doses, administered about a month apart.) Late last week, Dr. could have as many as 60 million doses of the vaccine ready by the end of the year. Department of Health and Human Services.)īetween Pfizer and Moderna, the U.S. I want to thank our partners at BARDA and Operation Warp Speed who have been instrumental to accelerating our progress to this point.” (BARDA is the Biomedical Advanced Research and Development Authority, part of the U.S. I want to thank the NIH, particularly NIAID, for their scientific leadership including through years of foundational research on potential pandemic threats at the Vaccine Research Center that led to the discovery of the best way to make Spike protein antigens that are being used in our vaccine and others’. All along, we have known that each day matters. Since early January, we have chased this virus with the intent to protect as many people around the world as possible. Stéphane Bancel, CEO of Moderna, said in a released statement, “This is a pivotal moment in the development of our COVID-19 vaccine candidate.

What’s Better Than One Effective COVID-19 Vaccine? Two Effective Vaccines!Īrguably even better news than hearing that Pfizer’s coronavirus vaccine is 90 percent effective: The pharmaceutical company Moderna announced this morning that the company’s “ experimental vaccine was 94.5 percent effective in preventing COVID-19 based on interim data from a late-stage clinical trial” and - this has big consequences for shipping and distribution - it can be stored in regular refrigerator temperatures. On the menu today: Moderna announces their coronavirus vaccine works and will be easier to store and transport than Pfizer’s the Georgia recount is almost done and a sneak preview of Hunting Four Horsemen about how regularly human beings come in contact with new viruses.

#Trumps cult animosity shows up trial

Vaccine trial participant David Rach is prepared to test coronavirus vaccine candidate BNT162b2, developed by Pfizer and BioNTech, at the University of Maryland School of Medicine in Baltimore, Md., May 24, 2020.